Trial Profile
Effect of a supratherapeutic dose of omarigliptin on the QTc interval in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2016
Price :
$35
*
At a glance
- Drugs Omarigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 14 Sep 2015 New trial record